FA
IMGN

FDx Advisors’s Immunogen Inc IMGN Stock Holding History

FDx Advisors’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,636
Closed -$28K – 660
2019
Q3 		$28K Buy
11,636
+126
+1% +$335 ﹤0.01% 624
2019
Q2 		$25K Buy
+11,510
New +$27.2K ﹤0.01% 801
2016
Q1 		– Sell
-10,674
Closed -$145K – 963
2015
Q4 		$145K Buy
+10,674
New +$131K 0.01% 841
2015
Q3 		– Sell
-12,641
Closed -$182K – 912
2015
Q2 		$182K Sell
12,641
-5,359
-30% -$58.9K 0.01% 897
2015
Q1 		$161K Buy
+18,000
New +$130K ﹤0.01% 1499

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

FDx Advisors's IMGN Position: Q4 2019 in Review

FDx Advisors sold out of Immunogen Inc (IMGN) in Q4 2019, closing a stake of 11,636 shares — an estimated $28K sold.

FDx Advisors first reported a position in IMGN in Q1 2015 and held it in 5 quarters. The position peaked at $182K in Q2 2015. 191 funds tracked by Wall St. Rank hold IMGN as of Q4 2019.

  • FDx Advisors reported no remaining Immunogen Inc position as of Q4 2019 after selling out during the quarter.
  • FDx Advisors sold 11,636 Immunogen Inc shares in Q4 2019, an estimated $28K.
  • FDx Advisors first reported a position in Immunogen Inc in Q1 2015 and held it in 5 quarters.
  • FDx Advisors's Immunogen Inc position peaked at $182K in Q2 2015.
  • 191 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2019.

Based on FDx Advisors's 13F filing for Q4 2019, filed 12 Feb 2020.